FDA inspection
Octapharma Plasma, Inc.: FDA inspection ending Aug 11, 2026
FDA inspection 1331976 · No Action Indicated (NAI) · Charlotte, NC
Key facts
| Inspection ID | 1331976 |
|---|---|
| Firm | Octapharma Plasma, Inc. |
| FEI number | 1071676 |
| City | Charlotte |
| State | NC |
| ZIP | 28215 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Aug 11, 2026 |
| Classification | No Action Indicated (NAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data